An integrative genomic and epigenomic approach for the study of transcriptional regulation

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Figueroa, Maria E ^a   Reimers, Mark ^b   Thompson, Reid F ^a   Ye, Kenny ^a   Li, Yushan ^a   Selzer, Rebecca R ^c   Fridriksson, Jakob ^c   Paietta, Elisabeth ^d   Wiernik, Peter ^d   Green, Roland D ^c   Greally, John M ^a   Melnick, Ari ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Roche NimbleGen Inc   (United States)

^d Our Lady of Mercy Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD135 ANTIGEN; CYTOSINE; DNA; DOCKING PROTEIN; HISTONE H3; LYSINE; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1; HISTONE; PRIMER DNA;

ACETYLATION; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CELL LINEAGE; CHROMOSOME 9Q; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC REGULATION; HUMAN; HUMAN CELL; LEUKEMIA; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PREDICTION; PROTEIN METHYLATION; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; CHROMATIN IMMUNOPRECIPITATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GENOMICS; LYMPHATIC LEUKEMIA; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ACETYLATION; BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA PRIMERS; GENE EXPRESSION REGULATION; GENOMICS; HISTONES; HUMANS; LEUKEMIA, MYELOID, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSCRIPTION, GENETIC;

EID: 46749153406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001882     Document Type: Article

References (40)

1. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293: 1074-1080.
2. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
3. Kurdistani SK, Tavazoie S, Grunstein M (2004) Mapping global histone acetylation patterns to gene expression. Cell 117: 721-733.
4. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, et al. (2005) Genomic maps and comparative analysis of historic modifications in human and mouse. Cell 120: 169-181.
5. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
6. Brinkman AB, Pennings SW, Braliou GG, Rieweld LE, Stunnenberg HG (2007) DNA methylation immediately adjacent to active historic marking does not silence transcription. Nucleic Acids Res.
7. Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG (2007) hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67: 194-201.
8. Bernstein BE, Humphrey EL, Erlich RL, Schneider R, Bouman P, et al. (2002) Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci U S A 99: 8695-8700.
9. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
10. Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116.
11. Melki JR, Vincent PC, Clark SJ (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 59: 3730-3740.
12. Tessema M, Langer F, Dingemann J, Ganser A, Kreipe H, et al. (2003) Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML). Leukemia 17: 910-918.
13. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797.
14. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, et al. (1998) Incidence and functional consequences of hMLHI promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95: 6870-6875.
15. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and historic deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107.
16. McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, et al. (2006) Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully cuchromatic chromatin state. Cancer Res 66: 3541-3549.
17. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
18. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47.
19. Valk PJ, Verhaak RG, Bejen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350: 1617-1628.
20. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947.
21. Berell M, Tortosa A, Verger E, Gil J, Viñolas N, et al. (2005) Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 11: 5167-5174.
22. Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, et al. (2004) CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res 10: 4933-4938.
23. Khulan B, Thompson R, Ye K, Fazzari MJ, Suzuki M, et al. (2006) Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Research 16: 1046-1055.
24. Melki JR, Clark SJ (2002) DNA methylation changes in leukaemia. Semin Cancer Biol 12: 347-357.
25. Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, et al. (2006) Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 66: 6118-6128.
26. Taylor KB, Pena-Hernandez KE, Davis JW, Arthur GL, Duff DJ, et al. (2007) Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res 67: 2617-2625.
27. Shi H, Wei SH, Leu YW, Rahmatpanah F, Liu JC, et al. (2003) Tripie analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Cancer Res 63: 2164-2171.
28. Wu J, Wang SH, Potter D, Liu JC, Smith LT, et al. (2007) Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. BMC Genomics 8: 131.
29. Chakrabarti SK, James JC, Mirmira RG (2002) Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdxl. Importance of chromatin structure in directing promoter binding. J Biol Chem 277: 13286-13293.
30. Oberley MJ, Tsao J, Yau P, Farnham PJ (2004) High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol 376: 315-334.
31. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, et al. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A 102: 15785-15790.
32. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
33. Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, et al. (2005) Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44: 305-319.
34. Reimers M, Weinstein JN (2005) Quality assessment of microarrays: visualization of spatial artifacts and quantitation of regional biases. BMC Bioinformatics 6: 166.
35. Eisen MB, Spellman PT, Brown PO, Berstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
36. Fellenberg K, Hauser NC, Brors B, Neutzner A, Hoheisel JD, et al. (2001) Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A 98: 10781-10786.
37. Misra J, Schmitt W, Hwang D, Hsiao LL, Gollans S, et al. (2002) Interactive exploration of microarray gene expression patterns in a reduced dimensional space. Genome Res 12: 1112-1120.
38. Team RDC (2007) R: A language and environment for statistical computing. 2.5.1 ed. Vienna: R Foundation for Statistical Computing.
39. Culhane AC, Thioulouse J, Perrierè G, Higgins DG (2005) MADE4: an R package for multivariate analysis of gene expression data. Bioinformatics 21: 2789-2790.
40. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996-1006.